researchintokyo.com

Japan Market Access

Japan Market Access

Home
Japan Market Access
- Coverage Decisions
- Pricing and Reimbursement
Approvals
- List of New Drugs/Indications Approved in Japan in 2014
Services
- Marketing Authorization
Blog
About Us
Contact Us

Recent Posts

Protected:
Anti-VEGF Battles: Eylea Overtakes Lucentis in Japan
iPS Cell Regenerative Medicine to Rely on Donor Cells in Order to Cut 77% of Costs
Plan: Generics to increase from 60% to 80% by 2017
Average Nursing Care Premium Breaks Through ¥5000

Contact Us

Your Name (required)

Your Email (required)

Subject

Your Message

· © 2026 researchintokyo.com · Designed by Press Customizr · Powered by ·